154 related articles for article (PubMed ID: 22956130)
1. Virtual ligand screening combined with NMR to identify Dvl PDZ domain inhibitors targeting the Wnt signaling.
Shan J; Zheng JJ
Methods Mol Biol; 2012; 928():17-28. PubMed ID: 22956130
[TBL] [Abstract][Full Text] [Related]
2. Identification of small-molecule compounds targeting the dishevelled PDZ domain by virtual screening and binding studies.
Choi J; Ma S; Kim HY; Yun JH; Heo JN; Lee W; Choi KY; No KT
Bioorg Med Chem; 2016 Aug; 24(15):3259-66. PubMed ID: 27112452
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a small-molecule inhibitor of Dvl-CXXC5 interaction by computational approaches.
Ma S; Choi J; Jin X; Kim HY; Yun JH; Lee W; Choi KY; No KT
J Comput Aided Mol Des; 2018 May; 32(5):643-655. PubMed ID: 29627878
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies.
Shan J; Zhang X; Bao J; Cassell R; Zheng JJ
Chem Biol Drug Des; 2012 Apr; 79(4):376-83. PubMed ID: 22172211
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the PDZ domain of mouse Dishevelled 1 and its interaction with CXXC5.
Lee I; Choi S; Yun JH; Seo SH; Choi S; Choi KY; Lee W
Biochem Biophys Res Commun; 2017 Apr; 485(3):584-590. PubMed ID: 27932247
[TBL] [Abstract][Full Text] [Related]
6. Identification of a specific inhibitor of the dishevelled PDZ domain.
Shan J; Shi DL; Wang J; Zheng J
Biochemistry; 2005 Nov; 44(47):15495-503. PubMed ID: 16300398
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index.
Hori K; Ajioka K; Goda N; Shindo A; Takagishi M; Tenno T; Hiroaki H
Front Pharmacol; 2018; 9():983. PubMed ID: 30233369
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled.
Grandy D; Shan J; Zhang X; Rao S; Akunuru S; Li H; Zhang Y; Alpatov I; Zhang XA; Lang RA; Shi DL; Zheng JJ
J Biol Chem; 2009 Jun; 284(24):16256-16263. PubMed ID: 19383605
[TBL] [Abstract][Full Text] [Related]
9. Autoinhibition of Dishevelled protein regulated by its extreme C terminus plays a distinct role in Wnt/β-catenin and Wnt/planar cell polarity (PCP) signaling pathways.
Qi J; Lee HJ; Saquet A; Cheng XN; Shao M; Zheng JJ; Shi DL
J Biol Chem; 2017 Apr; 292(14):5898-5908. PubMed ID: 28223363
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screen for small molecule inhibitors of Mint1-PDZ domains.
Chen X; Longgood JC; Michnoff C; Wei S; Frantz DE; Bezprozvanny L
Assay Drug Dev Technol; 2007 Dec; 5(6):769-83. PubMed ID: 18078379
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy.
Kim HY; Choi S; Yoon JH; Lim HJ; Lee H; Choi J; Ro EJ; Heo JN; Lee W; No KT; Choi KY
EMBO Mol Med; 2016 Apr; 8(4):375-87. PubMed ID: 26941261
[TBL] [Abstract][Full Text] [Related]
12. Accidental interaction between PDZ domains and diclofenac revealed by NMR-assisted virtual screening.
Tenno T; Goda N; Umetsu Y; Ota M; Kinoshita K; Hiroaki H
Molecules; 2013 Aug; 18(8):9567-81. PubMed ID: 23966078
[TBL] [Abstract][Full Text] [Related]
13. Discovery, structure-activity relationship studies, and crystal structure of nonpeptide inhibitors bound to the Shank3 PDZ domain.
Saupe J; Roske Y; Schillinger C; Kamdem N; Radetzki S; Diehl A; Oschkinat H; Krause G; Heinemann U; Rademann J
ChemMedChem; 2011 Aug; 6(8):1411-22. PubMed ID: 21626699
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Dvl PDZ domain inhibitor by exploring chemical space.
Shan J; Zheng JJ
J Comput Aided Mol Des; 2009 Jan; 23(1):37-47. PubMed ID: 18780146
[TBL] [Abstract][Full Text] [Related]
15. Target immobilization and NMR screening of fragments in early drug discovery.
Siegal G; Hollander JG
Curr Top Med Chem; 2009; 9(18):1736-45. PubMed ID: 19929836
[TBL] [Abstract][Full Text] [Related]
16. Integrating virtual screening in lead discovery.
Oprea TI; Matter H
Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
[TBL] [Abstract][Full Text] [Related]
17. NMR and in silico screening.
Rüdisser S; Jahnke W
Comb Chem High Throughput Screen; 2002 Dec; 5(8):591-603. PubMed ID: 12470256
[TBL] [Abstract][Full Text] [Related]
18. Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents.
Bouzidi N; Deokar H; Vogrig A; Boucherle B; Ripoche I; Abrunhosa-Thomas I; Dorr L; Wattiez AS; Lian LY; Marin P; Courteix C; Ducki S
Bioorg Med Chem Lett; 2013 May; 23(9):2624-7. PubMed ID: 23545111
[TBL] [Abstract][Full Text] [Related]
19. Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins.
Punchihewa C; Ferreira AM; Cassell R; Rodrigues P; Fujii N
Protein Sci; 2009 May; 18(5):994-1002. PubMed ID: 19388021
[TBL] [Abstract][Full Text] [Related]
20. NMR Methods for Identification of False Positives in Biochemical Screens.
Zega A
J Med Chem; 2017 Dec; 60(23):9437-9447. PubMed ID: 28657735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
